公开(公告)号：US20220220109A1

公开(公告)日：2022-07-14

申请号：US17613291

申请日：2020-05-27

Applicant: KOREA PHARMA CO., LTD.

Inventor： Soosung KANG ,  Eun Sun PARK ,  Eun Hee PARK ,  Seung Hee HAN

IPC: C07D471/04

Abstract: The present invention relates to a JAK inhibitor compound and a pharmaceutical composition including the same. More specifically, the present invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof and a pharmaceutical composition including the same. The structure of the compound of Formula I is described in the specification. The compound of the present invention can exhibit therapeutic effects on a variety of diseases, for example, inflammatory diseases, autoimmune diseases, myeloproliferative diseases, and human cancers due to its ability to regulate signal transduction at the level of JAK kinases.